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Supporting Methods 
X-ray CT imaging: CT images of the abdominal area (45 x 45 mm field-of-view) were 
acquired using 3D micro-CT (Rigaku) with a resolution of 90 μm, tube potential peaks of 90 
kV, tube current of 88 μA, and imaging duration of approximately 5 min. Mice were sedated 
during imaging using isoflurane (1%) at various time points after gavage. The magnets/non-
magnetic washers were removed prior to imaging and immediately re-attached afterwards. 
Thresholding and 3D image reconstruction was performed using ImageJ. 
MRI: Shortly after dissection, mouse intestines were fixed using 10% formalin at room 
temperature for 20 minutes. Fixed intestines were washed using cold PBS + 0.1 mM L-ascorbic 
acid and stored at 4oC until imaging. Before imaging, intestines were cast in a 1% (w/v) agarose 
gel phantom to minimize susceptibility artifacts. A Bruker 7 T small-animal scanner was used 
for all MR imaging, with a Rat volume coil (70 mm inner diameter) supplying the RF for 1H 
spin-excitation and subsequent readout. Given the high relaxivity of the micromagnets gavaged, 
a 3D UTE sequence (TE = 20 µs, TR = 8 ms, Navg = 2) was used to localize micromagnets within 
the intestines, using an isotropic voxel size of 234	µm. A 3D FLASH sequence, with an 
isotropic voxel size of 325	µm, was used to obtain anatomical images of the ex vivo GI tract 
specimens. 
Scaling estimations: To estimate the approximate sizes of the external wearable magnet 
and internal micromagnets needed to use CLAMP in larger animals such as humans, we first 
approximate the wearable magnets as a sphere. This approximation yields an order-of-
magnitude scaling insight into the relevant sizes of the magnets used for CLAMP, as well as 
the expected field and field-gradient strengths. Furthermore, we neglect any azimuthal 





Here, 𝑧  is the axial distance from the center of the spherical magnet, 𝑀  is the volume 
magnetization, 𝑅magnet is the magnet’s radius, and 𝜇! is the permeability of free space constant. 








Substituting these expressions into equation 1 (see main text), the magnitude of the force on the 
micromagnets is approximated by equation 4: 










Where 𝑅bead is the radius of the micromagnets and ∆χ is the difference in magnetic susceptibility 
between the micromagnets and the surrounding medium. In mice, the small intestine is at an 
average distance of 10 mm from the abdominal surface; in humans the small intestine is at an 
typical distance of 60 mm[2,3]. From our in vivo results, we can conclude that the magnetic 
forces achieved by CLAMP are sufficient to arrest downstream peristaltic transport of the 
composite biomagnetic material once formed at a desired GI locus. Similar magnetic forces 
need to be achieved in larger animals to obtain similar retention of magnetized cells and 
particles. If we assume that the same magnetic materials are used in larger animals, then 𝑀 and 








Here we specifically provide the scaling relationship for use of CLAMP in humans, but the 
approach is generalizable to any other animal. In our in vivo experiments with mice, the 
micromagnets had an average diameter of 1.5 µm, so 𝑅bead,	mouse = 7.5 × 105)	mm; and the 
volume of the wearable magnet array was 1.54 cm3 , so the equivalent radius is 𝑅magnet,	mouse =
7.16	mm. To estimate the radius of micromagnets and the permanent magnet needed for use in 
humans, these values were plugged into equation 5 and 𝑅bead,	human was solved for using 
varying values of 𝑅magnet,	human in MATLAB (Figure S7).  
 
Supporting References 
[1] J. M. Camacho, V. Sosa, Rev. Mex. Fis. E 2013. 
[2] “Small bowel mri (enterography) planning and preparation | mri enteroclysis protocols 
and indications,” can be found under https://mrimaster.com/PLAN SMALL 
BOWEL.html, n.d. Accessed January 2021.  
[3] “abdomen anatomy | MRI abdomen axial anatomy | free cross sectional anatomy |,” can 
be found under https://mrimaster.com/anatomy abdomen axial.html, n.d. Accessed 
January 2021. 
  






Figure S1. X-ray CT data. a,b, Representative sagittal (a) and coronal (b) X-ray CT images 
of the mouse GI tract after oral gavage of a CT contrast agent (Isovue-370). c, Representative 
images before gavage, 45-min post-gavage, and 65 min post-gavage of a mixture of 
micromagnets. The mouse was fasted prior to gavage and given only sucrose water after 
gavage. The white arrows point to the micromagnets remaining in the stomach. d,e, 
Representative images of mice at 6 hours after gavage of micromagnets without bicarbonate 
(d) and with bicarbonate (e). Mice in (d) were given normal solid food after gavage while 
mice in (e) were given sucrose water after gavage; both were fasted prior to gavage. Arrows 
in (d) point to the signal from iron accumulation in the bladder; no signal from the bladder 
was observed in (e). All scale bars are 10 mm.  




Figure S2. Characterization of particles and cells. a, Zeta potential measurements of 
BL21(DE3) E. coli, 0.5 μm fluorescent polystyrene particles, magnetic label (150 nm 
streptavidin-coated superparamagnetic iron oxide nanoparticles, SA-SPION), and 
micromagnets (BioMag Carboxyl) used in this study. b, Hydrodynamic radius measured by 
DLS of 0.5 μm fluorescent polystyrene particles, magnetic label (SA-SPION), SPION-labeled 
particles, Neutravidin (NA)-labeled particles, and micromagnets (BioMag Carboxyl) used in 
this study in water and 100 mM MgCl2. c, Hydrodynamic radius measured by DLS of 
micromagnets (BioMag Carboxyl) as a function of MgCl2 concentration. 
  





Figure S3. Additional simulation results for the magnet array. a, Schematic of magnet 
array of 3 x 2 B444-N52 magnets used in in vivo experiments. The magnets were arranged in 
a checkerboard pattern of alternating magnetization to maximize areas of high field and field 
gradient strength. b,c, Simulation of the magnetic flux density (b) and magnetic field gradient 
(c) at the surface of the magnet array.  





Figure S4. Representative ex vivo MRI on mouse small intestines. a, T1 weighted 
anatomical image alongside b, T2 weighted image of a mouse small intestine (SI), with 
arrows indicating regions of susceptibility artefacts which are caused by the presence of 
micromagnets. The SI was isolated from a mouse 9h post-gavage. A magnet was placed on 
the mouse abdomen 75 mins after gavage with the micromagnet and synthetic-cell mixture. c, 
T1 weighted anatomical image alongside d, T2 weighted image of a mouse SI 9h post gavage. 
A non-magnetic washer of equivalent weight was placed on the mouse abdomen 75 mins after 
gavage with the same experimental mixture as in (a). No susceptibility artefacts were 
observed in the SI as evidenced by the lack of T2* blooming in the T2 weighted image. e, T1 
and f, T2 weighted images of a control mouse SI respectively. The mouse was not gavaged 
with any beads but was maintained under the same experimental conditions as in (a) and (c). 
The SI was dissected from the GI tract and placed within an agarose matrix to minimize 
susceptibility artefacts during imaging. All scale bars are 20 mm. 
  




Figure S5. Co-localization of magnetically-labeled E. coli and particles with 
micromagnets in vivo. a-b, Fraction of SPION-labeled E. coli (a) and SPION-labeled 
particles (b) retained in small intestinal segments where micromagnets were observed or 
absent in a given mouse. Small intestinal segments SI-1 through SI-4 (see Figure 3d-e) were 
examined by eye for the presence of micromagnets before quantification of the E. coli or 
particles retained. Lines represent the mean and error bars represent the SEM. Asterisks 
represent statistical significance by the Welch’s t test (**** = p<0.0001, ns=no significance).  




Figure S6. In vitro efficacy of CLAMP with particles. In vitro capture of non-magnetic and 
magnetized 0.5 μm fluorescent particles without micromagnets, with micromagnets, and with 
clustered micromagnets. The experimental setup is as illustrated in Figure 2 except with 
particles instead of E. coli. Asterisks represent statistical significance by Welch’s t test (*** = 
p<0.001, ** = p<0.01, ns = no significance).  




Figure S7. Estimates for scaling CLAMP to humans. Radius of internal micromagnets 
versus equivalent radius of wearable magnet needed to achieve sufficient force to CLAMP 
cells in the small intestine of humans. The orange dotted line indicates the radius of 
micromagnets used in our in vivo experiments with mice. Here, we assumed that the wearable 
magnet is spherical, the small intestine is at a distance of 6 cm from the abdominal skin, and 
the micromagnets and wearable magnet are made of the same materials as those used in our 
studies with mice. See supporting methods section for more details. 
